A comparison of the effectiveness of three regimens in the prevention of pneumocystis carinii pneumonia in human immunodeficiency virus-infected patient
Martin MA, Cox PH, Beck K, et al. A comparison of the effectiveness of three regimens in the prevention of pneumocystis carinii pneumonia in human immunodeficiency virus-infected patient. Arch Intern Med 1992;152:523-528.
Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS
Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988;259:1185-1189.
Efficacy and safety of rechallenge with low-dose trimethoprim-sulfamethoxazole in previously hypersensitive HIV-infected patients
Carr A, Penny R, Cooper DA. Efficacy and safety of rechallenge with low-dose trimethoprim-sulfamethoxazole in previously hypersensitive HIV-infected patients. AIDS 1993;7:65-71.
Frequency of serious adverse reactions to trimethoprim-sulfamethoxazole and pentamidine among children with human immunodeficiency virus type 1 infection
Los Angelos, CA
McSherry G, Wright M, Oleske J, et al. Frequency of serious adverse reactions to trimethoprim-sulfamethoxazole and pentamidine among children with human immunodeficiency virus type 1 infection. (Abstract 1357) International Conference of Antimicrobial Agents and Chemotherapy, Los Angelos, CA, 1988.